Literature DB >> 16790367

Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.

Patrick Lebecque1, Teresinha Leal, Katia Zylberberg, Grégory Reychler, Xavier Bossuyt, Véronique Godding.   

Abstract

BACKGROUND: Data from the Belgian Cystic Fibrosis Registry consistently show that in one of the seven reference centres, the prevalence of Pseudomonas aeruginosa is half that observed at the national level.
OBJECTIVES: To report the characteristics of non-transplanted patients in this clinic at the end of 2003, with special focus on paediatric patients. To describe and discuss our policy of inhaled antibiotic therapy.
FINDINGS: The prevalence of P. aeruginosa among 116 patients is 20.7%. The chronic colonization rate is 19.8% but only 2.8% in patients aged under 18 (n=72). Serologic data strongly support these results. Most paediatric patients (95%) are prescribed inhaled antibiotics, at least on an intermittent basis but the mean number of days of intravenous antibiotic treatment is four times lower than in other CF children in Belgium. 70% of children have an FEV1> or =90% predicted. DISCUSSION: We have reported a distinctly low rate of chronic colonization by P. aeruginosa in a cohort of CF children and suspect that a strategy of early, often <<prophylactic>> use of inhaled antibiotics, progressively implemented for over 15 years has substantially contributed to these results. Given the major impact of chronic P. aeruginosa colonization on prognosis in CF, it is suggested that a large prospective study of this approach is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790367     DOI: 10.1016/j.jcf.2006.04.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  3 in total

Review 1.  Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment.

Authors:  Luiz Vicente Ribeiro Ferreira da Silva Filho; Flavia de Aguiar Ferreira; Francisco José Caldeira Reis; Murilo Carlos Amorim de Britto; Carlos Emilio Levy; Otavio Clark; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

2.  A cross-sectional study of growth, nutritional status and body proportions in children and adolescents at a medical center specializing in the treatment of cystic fibrosis in Poland.

Authors:  Dorota Sands; Wioleta Umławska; Anna Zielińska
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

3.  Cystic fibrosis in Tunisian children: a review of 32 children.

Authors:  Khedija Boussetta; Fatma Khalsi; Yasmine Bahri; Imen Belhadj; Faten Tinsa; Taieb Ben Messaoud; Samia Hamouda
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.